Valsartan/sacubutril
Article Sidebar
Main Article Content
บทคัดย่อ
-
Article Details
เอกสารอ้างอิง
CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-35.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation [Internet].2013[cited 2019 Aug 12];128(16):e240-e327. Available from: https://www.ahajournals.org/doi/epub/10.1161/CIR.0b013e31829e8776
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004.
Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-49.
Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, TristaniFE,et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study.N Engl J Med 1986;314:1547-52.
CohnJN, Johnson G,ZiescheS, Cobb F, Francis G, Felix T, etal. A comparison of enalapril with hydralazine-isosorbidedinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-10.
Braunwald E. The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure. J Am CollCardiol 2015;65:1029-41.
McDowell G, Nicholls DP. The therapeutic potential of candoxatril, a neutral endopeptidase inhibitor, in humans.Cardiovasc Drug Rev 2000;18:259-70.
Packer M, Califf RM, Konstam MA, Krum H, McMurray JJ, Rouleau JL, et al. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation2002; 106:920-26.
Kostis JB, Packer M, Black HR, Schmieder R, Henry D, Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004;17:103-11.
